Gritstone bio Inc expected to post a loss of 33 cents a share - Earnings Preview

Gritstone bio

30/10/2023 13:11

* Gritstone bio Inc  GRTS.OQ   GRTS.O  is expected to show a
fall
in quarterly revenue when it reports  results 
    * The Emeryville California-based  company is expected to
report 
a 37.3% decrease in revenue to $1.894 million from $3.02 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Gritstone bio Inc
is for
a loss of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gritstone
bio Inc
is $8​, above​ its last closing price of $1.89. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.33       -0.35      -0.31     Beat    10.5
 Mar. 31 2023  -0.33       -0.33      -0.30     Beat    10.3
 Dec. 31 2022  -0.31       -0.34      -0.30     Beat    12.8​
 Sep. 30 2022  -0.37       -0.40      -0.35     Beat    12.1
 ​​Jun.        -0.39       -0.40      -0.34     Beat    14.1
 30 2022                                                
 Mar. 31 2022  -0.35       -0.37      -0.34     Beat    7.5​
 Dec. 31 2021  -0.34       -0.38      -0.37     Beat    3.3
 Sep. 30 2021  -0.49       -0.52      -0.36     Beat    30.6
 This summary was machine generated October 30 at 13:11 GMT.  All
figures in US dollars  unless otherwise stated